Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

Who is the Target Population for Cabotegravir?

SEP 06, 2017 | CONTAGION® EDITORIAL STAFF


Alex Rinehart, PhD, Director, Global Prevention Strategy, ViiV Healthcare, explains who the target population is for cabotegravir. Dr. Rinehart stresses that essentially, anyone who is at risk for HIV can use cabotegravir as a preventive option against the virus.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.